Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.

By P. Devereaux, Homer Yang, S. Yusuf, G. Guyatt, K. Leslie, J. Villar, D. Xavier, S. Chrolavicius, Launi Greenspan, Janice Pogue and 9 more. The Lancet, 2008

2,045 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/382a51531f743f40812243af61d88bcedca354fb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Douglas G. Altman
2. David Moher
3. P. Gøtzsche
4. K. F. Schulz
5. P. Devereaux
6. Victor M. Montori
7. Sally Hopewell
8. Matthias Egger

In Pulmonary and Respiratory Medicine

1. Douglas G. Altman

In Surgery

1. David Moher
2. Douglas G. Altman
3. M. H. Murad
4. Matthias Egger
5. K. Thorlund
6. A. Vedel

Citations in the corpus

• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010, methodology): “Patients whose heart rate was consistently 45e49 bpm and systolic blood pressure exceeded 100 mm Hg delayed taking the study drug for 12 h’’[100].”
• GRADE guidelines 6. Rating the quality of evidence--imprecision. (2011, methodology): “Consider, for instance, the systematic review of b blockers in noncardiac surgery mentioned previously [23].”
• Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. (2017, background): “58 The meta-analysis showed that the increased risk of death and stroke was qualitatively unchanged without the POISE data.”